During the past decade, Taipei Tzu Chi Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taipei Tzu Chi Hospital" #1 sponsor was "Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation" with 16 trials, followed by "National Taiwan University Hospital" with 5 trials sponsored, "BeiGene" with 2 trials sponsored, "Concept Medical Inc." with 2 trials sponsored and "AbbVie" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Tzu Chi Hospital" #1 collaborator was "National Science Council, Taiwan" with 4 trials as a collaborator, "Taichung Tzu Chi Hospital" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Buddhist Tzu Chi General Hospital" with 1 trials as a collaborator and "Centre Hospitalier Régional Universitaire de Nancy" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Taipei Tzu Chi Hospital" are "Autonomic Dysfunction" (3 trials), "Chronic Kidney Diseases" (3 trials), "Atherosclerosis" (2 trials), "Cerebrovascular Accident" (2 trials) and "Healthy" (2 trials). Many other conditions were trialed in "Taipei Tzu Chi Hospital" in a lesser frequency.

Most popular intervention types in "Taipei Tzu Chi Hospital" are "Drug" (11 trials), "Other" (8 trials), "Device" (4 trials), "Behavioral" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ociperlimab" (2 trials), "Tislelizumab" (2 trials), "5fluorouracil" (1 trials) and "AST-120" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taipei Tzu Chi Hospital" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Taipei Tzu Chi Hospital". undefined are not yet recruiting, 10 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Taipei Tzu Chi Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Taipei Tzu Chi Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".